Simulations Plus to Present at Oppenheimer Healthcare Conference
March 09 2021 - 08:30AM
Business Wire
Simulations Plus, Inc. (Nasdaq: SLP), a premier provider of
simulation and modeling software and consulting services for
pharmaceutical discovery and development, today announced that
Shawn O’Connor, chief executive officer, will be presenting at
Oppenheimer’s 31st Annual Healthcare Conference on Tuesday, March
16, 2021. Mr. O’Connor’s presentation, which will be webcast live,
will begin at 2:30 p.m. ET. In addition, Mr. O’Connor and chief
financial officer Will Frederick will host one-on-one meetings
throughout the day.
The Company’s slide presentation will be available on the
Investors page of the Simulations Plus website following the
presentation. For more information about the Oppenheimer Annual
Healthcare Conference, or to register to attend, please visit the
conference website.
About Simulations Plus, Inc.
Simulations Plus, Inc., is a leading provider of modeling and
simulation software and consulting services supporting drug
discovery, development research, and regulatory submissions. With
our subsidiaries, Cognigen, DILIsym Services, and Lixoft, we offer
solutions which bridge machine learning, physiologically based
pharmacokinetics, quantitative systems pharmacology/toxicology, and
population PK/PD modeling approaches. Our vision is to improve
health through innovative solutions, and our mission is to create
value for our customers by accelerating and reducing the costs of
R&D through innovative science-based software and consulting
solutions that optimize treatment options and improve patient
lives. For more information, please visit our website at
www.simulations-plus.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20210309005400/en/
Simulations Plus Investor Relations
Ms. Renee Bouche 661-723-7723 renee@simulations-plus.com
Hayden IR Mr. Cameron Donahue
651-653-1854 slp@haydenir.com
Simulations Plus (NASDAQ:SLP)
Historical Stock Chart
From Feb 2024 to Mar 2024
Simulations Plus (NASDAQ:SLP)
Historical Stock Chart
From Mar 2023 to Mar 2024